Skip to main content

Root Jonathan D's Form 4 filing

eFFECTOR Therapeutics, Inc. (EFTR) · filed Nov 12, 2021

Accession no.
0001062993-21-010759
Filed
Nov 12, 2021
Trade date
Nov 9-12, 2021
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions and 0 derivative transactions. Open-market sales total $917.1K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Root Jonathan DCIK 0001225480Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 9, 2021Common StockSSaleDisposed−27,892$11.00−$306,8124,644,736Indirect
Nov 9, 2021Common StockSSaleDisposed−893$11.00−$9,823148,593Indirect
Nov 10, 2021Common StockSSaleDisposed−32,946$10.44−$343,956.244,611,790Indirect
Nov 10, 2021Common StockSSaleDisposed−1,054$10.44−$11,003.76147,539Indirect
Nov 11, 2021Common StockSSaleDisposed−11,644$10.37−$120,748.284,600,146Indirect
Nov 11, 2021Common StockSSaleDisposed−373$10.37−$3,868.01147,166Indirect
Nov 12, 2021Common StockSSaleDisposed−11,628$10.07−$117,093.964,588,518Indirect
Nov 12, 2021Common StockSSaleDisposed−372$10.07−$3,746.04146,794Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)